RxSIGHT, INC. (RXST) stock plummeted 6.06% on Wednesday, likely due to a series of analyst rating and price target adjustments.
BTIG lowered its price target on RXST from $58 to $44, although it maintained a Buy rating. The firm's decision to lower the price target could have contributed to the stock's decline, as it reflects a more conservative valuation outlook.
Meanwhile, Stifel Nicolaus maintained a Hold rating on RXST and set a price target of $33, while Needham reiterated its $43 price target on the stock. These neutral-to-negative analyst actions may have weighed on investor sentiment, leading to the selloff in RXST shares.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。